drugset / Trial / NCT01918709

Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers

NCT01918709

Phase 1 Completed 30 enrolled LG Life Sciences
RandomizedCrossoverOpen-labelTreatment

Summary

Primary objective : To investigate pharmacokinetics after concomitant administration of valsartan and rosuvastatin compared to single administration of valsartan or rosuvastatin in healthy male volunteers Secondary objective : To investigate safety profiles after the administration of valsartan or rosuvastatin alone and concomitant administration of valsartan and rosuvastatin in healthy male volunteers

Timeline

Start
2011-09
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg Oral
Subject Valsartan Small molecule 160 mg Oral

Indications